Gut health has experienced an intriguing market trajectory. Once a clinical conversation confined to gastroenterology, it now plays out on social feeds, supermarket shelves and in the everyday language of shoppers. Fibremaxxing has become a genuine trend, prebiotic sodas have moved from niche to the mainstream, and consumers are better informed than ever. They are arriving at the health and nutrition aisles with expectations that would have seemed improbable only a few years ago.
That shift is good news for our industry, but it raises the industry bar. A gut health claim on the front of pack by itself no longer does the persuading it once did. Increasingly, shoppers want to know what an ingredient actually does, at what dose, and with what evidence. The question when developing the next generation of products is how to build products credible enough to earn a discerning consumer's trust - and keep it.
Meeting that expectation means holding three things together at once: a meaningful outcome that the consumer can feel, a format they can conveniently use every day, and science robust enough to validate any claims made. Ingredients that satisfy one but not the others will struggle as scrutiny grows.
This is where a targeted prebiotic can make all the difference. Bimuno® GOS, our galactooligosaccharide ingredient, is the most extensively studied prebiotic of its type, supported by more than 135 scientific publications, including over 25 clinical studies. That evidence base is what enables a brand to be specific in its language, rather than vague.
Bimuno GOS selectively nourishes beneficial bifidobacteria, producing a measurable bifidogenic effect in around a week, and human studies show it can ease the everyday complaints that matter most to consumers, from bloating and flatulence to abdominal discomfort and pain. Its influence in areas such as gastrointestinal, immune and brain health has been extremely well-documented.
Specificity of that kind is precisely what the better-informed shopper responds to. It lets a product move beyond a generic gut health promise to a benefit that is named, measurable and defensible.
Just as importantly, the science comes without demanding compromises elsewhere in formulation. Bimuno GOS works at a low effective dose, delivering its benefit without dominating a formulation or forcing unwelcome trade-offs on taste and texture. It is stable across a broad range of pH and temperature conditions, making it straightforward to work with across powders, capsules, gummies and functional foods, as well as further afield in categories such as ready-to-drink beverages. That combination of evidence and ease is what turns a promising concept into a product that reaches the shelf.
The market's growing sophistication is an opportunity not to be missed. As consumers ask more science-led questions, the standout brands will be those that can answer them with credible science and deliver on the promise.
These are exactly the conversations we look forward to at SupplySide Global 2026, where the Clasado team will be on stand 4249, exploring how robust prebiotic science can help formulators turn rising gut health expectations into better, more differentiated products.
Ultimately, a more knowledgeable consumer is the best thing that could happen to gut health. It rewards the brands doing the hard work in grounding their claims in evidence rather than optimism and lifts the standard for the whole category. That is a future worth nurturing; one where better science makes for better products, and better products earn the kind of consumer trust that lasts.
Discover how Bimuno GOS can support your next gut health formulation
Written by Marcelo Durante, Sales & Marketing Director, Clasado Biosciences
